REFERENCE
Lindgren A, Schwander B, Zöllner Y, Jönsson B.Cost-utility analysis of eprosartan compared to enalapril and ramipril in the treatment of moderate to severe hypertension in Sweden. Value in Health 9: A353 (plus poster) abstr. PCV53, No. 6, Nov-Dec 2006
Rights and permissions
About this article
Cite this article
Eprosartan cost effective for hypertension in Sweden. Pharmacoecon. Outcomes News 521, 9 (2007). https://doi.org/10.2165/00151234-200705210-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705210-00028